Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer

被引：0
|
作者：
Sheng Zhang
Yongzhi Yang
Wenhao Weng
Bomin Guo
Guoxiang Cai
Yanlei Ma
Sanjun Cai
机构：
[1] Fudan University Shanghai Cancer Center,Department of Colorectal Surgery
[2] Fudan University,Department of Oncology, Shanghai Medical College
[3] Tongji University School of Medicine,Department of Clinical Laboratory, Yangpu Hospital
[4] Tongji University School of Medicine,Center for Translational Medicine, Yangpu Hospital
[5] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Surgery
来源：
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词：
BIRC3; 5-fluorouracil; Chemoresistance; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
    M Karaayvaz
    H Zhai
    J Ju
    Cell Death & Disease, 2013, 4 : e659 - e659
  • [32] miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
    Karaayvaz, M.
    Zhai, H.
    Ju, J.
    CELL DEATH & DISEASE, 2013, 4 : e659 - e659
  • [33] FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis
    He, Zhanke
    Yang, Junbo
    Sui, Chuyang
    Zhang, Penghao
    Wang, Ting
    Mou, Tingyu
    Sun, Kai
    Wang, Yanan
    Xu, Zhijun
    Li, Guoxin
    Deng, Haijun
    Shi, Jiaolong
    Zhuang, Baoxiong
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2022, 722
  • [34] Fluctuation in Plasma 5-Fluorouracil Concentration During Continuous 5-Fluorouracil Infusion for Colorectal Cancer
    Matsumoto, Hideo
    Okumura, Hideo
    Murakami, Haruaki
    Kubota, Hisako
    Higashida, Masaharu
    Tsuruta, Atsushi
    Tohyama, Kaoru
    Hirai, Toshihiro
    ANTICANCER RESEARCH, 2015, 35 (11) : 6193 - 6199
  • [35] Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1
    Rubinstein, Mara Roxana
    Baik, Jung Eun
    Lagana, Stephen M.
    Han, Richard P.
    Raab, William J.
    Sahoo, Debashis
    Dalerba, Piero
    Wang, Timothy C.
    Han, Yiping W.
    EMBO REPORTS, 2019, 20 (04)
  • [36] Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer
    Zhong, Chunge
    Wang, Shengnan
    Jiang, Wen-Jie
    Li, Zexu
    Wang, Xiaofeng
    Fan, Shuangshuang
    Huang, Jun
    Wu, Hua-Jun
    Sheng, Ren
    Fei, Teng
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [37] Prediction of sensitivity to 5-fluorouracil by quantitative measurement of 5-fluorouracil metabolism-relating gene expression in gastric and colorectal cancer.
    Terashima, M
    Kato, M
    Satoh, Y
    Odashima, Y
    Soeta, N
    Ohtani, S
    Kashimura, S
    Hoshino, Y
    Kogure, M
    Gotoh, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 343S - 343S
  • [38] Exploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer
    Bostanghadiri, Narjess
    Razavi, Shabnam
    Shariati, Aref
    Talebi, Malihe
    Mirkalantari, Shiva
    Emami Razavi, Amirnader
    Darban-Sarokhalil, Davood
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [39] SLC12A8 upregulation promotes colorectal cancer progression and chemoresistance
    Sun, Zhe
    Nie, Zhiyan
    Xu, Yao
    Cui, Yingshun
    Ma, Wenjian
    Zhang, Tongcun
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (07)
  • [40] Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer
    Fioravanti, Anna
    Canu, Bastianina
    Ali, Greta
    Orlandi, Paola
    Allegrini, Giacomo
    Di Desidero, Teresa
    Emrilenegger, Urban
    Fontanini, Gabriella
    Danesi, Romano
    Del Tacca, Mario
    Falcone, Alfredo
    Bocci, Guido
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 619 (1-3) : 8 - 14
12345